Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 16/20 | 0.68 |
| ▸ | CA1 | P00915 | 15/20 | 0.68 |
| ▸ | CA12 | O43570 | 4/20 | 0.68 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 8/20 | 0.43 |
| ▸ | CA7 | P43166 | 3/20 | 0.41 |
| ▸ | CA3 | P07451 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3790104 | 0.98 | CA2 (0.65) | CA2CA1CA12CA14TP53 | |
| SCHEMBL3793002 | 0.98 | CA2 (0.65) | CA2CA1CA12CA14TP53 | |
| SCHEMBL293121 | 0.98 | CA2 (0.65) | CA2CA1CA12CA14TP53 | |
| SCHEMBL25129256 | 0.98 | CA2 (0.65) | CA2CA1CA12CA14TP53 | |
| SCHEMBL15546426 | 0.98 | CA2 (0.65) | CA2CA1CA12CA14TP53 | |
| SCHEMBL23319282 | 0.98 | CA2 (0.65) | CA2CA1CA12CA14TP53 | |
| SCHEMBL3795610 | 0.98 | CA2 (0.65) | CA2CA1CA12CA14TP53 | |
| SCHEMBL8215971 | 0.93 | CA2 (0.74) | CA2CA1CA12CA14TP53 | |
| SCHEMBL8219345 | 0.93 | CA2 (0.74) | CA2CA1CA12CA14TP53 | |
| SCHEMBL293306 | 0.92 | CA1 (0.71) | CA2CA1CA12CA14TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009124872-A2 | ANIONIC DYES AND HAIR DYE COMPOSITIONS CONTAINING THEM | DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) | 2009-10-15 | — | — | WO | claimed |
| EP-2108406-A1 | Anionic dyes and hair dye compositions containing them | DyStar Textilfarben GmbH & Co. Deutschland KG (DE) | 2009-10-14 | — | — | EP | claimed |
| EP-0075230-B1 | ANAEROBICALLY CURABLE ADHESIVE | Teroson GmbH (DE) | 1984-06-06 | — | — | EP | claimed |
| JP-62238789-A | — | — | None | — | — | JP | disclosed |
| EP-2168181-B1 | MIXTURES FOR PRODUCING PHOTOACTIVE LAYERS FOR ORGANIC SOLAR CELLS AND ORGANIC PHOTODETECTORS | HELIATEK GMBH (DE) | 2021-05-12 | — | — | EP | disclosed |
| US-9831042-B2 | Organic dyes comprising a hydrazone moiety and their use in dye-sensitized solar cells | BASF SE (DE) | 2017-11-28 | — | — | US | disclosed |
| US-20160126022-A1 | ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS | BASF SE (DE) | 2016-05-05 | — | — | US | disclosed |
| EP-2870204-A2 | ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS | BASF SE (DE) | 2015-05-13 | — | — | EP | disclosed |
| WO-2014006544-A2 | ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS | BASF SE (DE) | 2014-01-09 | — | — | WO | disclosed |
| US-8158790-B2 | Cyclic amine compound | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-04-17 | — | — | US | disclosed |
| EP-2036896-B1 | CYCLIC AMINE COMPOUND | DAIICHI SANKYO CO LTD (JP) | 2012-03-14 | — | — | EP | disclosed |
| WO-2003002705-A1 | PREPARATION OF CELLULOSIC MATERIALS | NOVOZYMES NORTH AMERICA, INC. (US) | 2003-01-09 | — | — | WO | disclosed |
| EP-1230210-A1 | AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-08-14 | — | — | EP | disclosed |
| EP-0736575-B1 | Azamethine dyes with heterocyclic side groups | BASF AG (DE) | 2001-10-24 | — | — | EP | disclosed |
| WO-2001036375-A1 | AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-25 | — | — | WO | disclosed |
| EP-0796297-B1 | METHINE DYES BASED ONE FORMYLAMINOPYRIDONES | BASF AG (DE) | 1999-04-07 | — | — | EP | disclosed |
| US-5849361-A | Methine dyes based on formylaminopyridones | BASF AKTIENGESELLSCHAFT (DE) | 1998-12-15 | — | — | US | disclosed |
| US-5773623-A | Methine dyes containing a 5- or 6- membered carbocyclic or heterocyclic radical | BASF AKTIENGESELLSCHAFT (DE) | 1998-06-30 | — | — | US | disclosed |
| EP-0736575-A2 | Azamethine dyes with heterocyclic side groups | BASF AKTIENGESELLSCHAFT (DE) | 1996-10-09 | — | — | EP | disclosed |
| JP-S62238789-A | THERMAL RECORDING MATERIAL | RICOH CO LTD | 1987-10-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160126022-A1 | ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS | C1S, C9, C1R | CA2 174/4885CA1 294/4885CA12 164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.